Delivery Order SPE2DB22D1202-SPE2DB25FVEL5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,755.67. This is a firm fixed-price delivery order with an ultimate completion date of May 22, 2025, representing a short-term pharmaceutical procurement. The award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,187.40 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg, with an ultimate completion date of September 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,388.24 delivery order to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) with an ultimate completion date of September 29, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price contract utilizes no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,587.03. This non-set-aside, competitively awarded delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,445.57 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed price contract type. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $3,846.89. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $3,631.72 to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $5,587.61. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 21, 2025. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,146.35 for Adderall XR 20 mg capsules (100 count) on June 2, 2025, with completion scheduled for June 3, 2025. This contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's significantly larger...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVEL5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,388.00 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units). This firm fixed-price, non-set-aside contract was awarded on July 11, 2025, with an ultimate completion date of July 14, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's pharmaceutical supply relationship with the federal government, specifically supporting military and federal healthcare systems' medication procurement needs. This award is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies across multiple therapeutic domains to support military healthcare programs and other federal healthcare systems worldwide. The company's competitively awarded contracts demonstrate its capability to fulfill federal requirements for both routine medications and specialized pharmaceutical products at varying order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/11/25 |